Sinet P M, Verdier F, Charmot G, Desforges B, Gaudin C, Pocidalo J J
INSERM Unité 13, Institut de Médecine et d'Epidémiologie africaines, Paris.
Bull Soc Pathol Exot. 1996;89(3):175-8.
The wide use of chloroquine (Cq) for prophylaxis and chemotherapy of malaria in Africa, and the increased spread of AIDS in areas of this continent where malaria is endemic, raised the question of a possible interaction between chloroquine intake and HIV infection. Indeed, hydroxychloroquine and chloroquine itself have been shown to inhibit HIV-1 replication in vitro, hydroxychloroquine being proposed as a potential useful adjunctive therapy in the treatment of HIV-1 infection. On the other hand, chloroquine has been reported to enhance the replication of Semliki forest and encephalomyocarditis viruses in a mouse model. In an attempt to elucidate Cq effect on retroviral replication, we have studied the effect of various concentrations of chloroquine in vitro (0.1 nmol/l to 25 mumol/l) on Friend retrovirus (FV)-infected fibroblasts of mice and in vivo (2 to 30 mg/kg) on FV-infected mice. No reduction in the number of virus foci was found in chloroquine-treated fibroblasts cultures. In chloroquine treated-infected mice, no differences were observed in the spleen weights, except an increase at 10 mg/kg. A decrease in splenocyte virus titer was only observed at 10 and 30 mg/kg. No differences in the median survival time was observed up to 30 mg/kg. The authors concluded that chloroquine seemed to have variable effects on viral replication in vivo depending on the dosage, but has no influence on the course of FV-induced disease.
氯喹(Cq)在非洲被广泛用于疟疾的预防和化疗,且在该大陆疟疾流行地区艾滋病的传播日益增加,这引发了服用氯喹与HIV感染之间可能存在相互作用的问题。事实上,羟氯喹和氯喹本身已被证明在体外可抑制HIV-1复制,羟氯喹被提议作为治疗HIV-1感染的一种潜在有用的辅助疗法。另一方面,据报道氯喹在小鼠模型中可增强Semliki森林病毒和脑心肌炎病毒的复制。为了阐明Cq对逆转录病毒复制的影响,我们研究了不同浓度的氯喹(体外0.1 nmol/l至25 μmol/l)对感染Friend逆转录病毒(FV)的小鼠成纤维细胞以及体内(2至30 mg/kg)对感染FV的小鼠的影响。在经氯喹处理的成纤维细胞培养物中未发现病毒灶数量减少。在经氯喹处理的感染小鼠中,除10 mg/kg剂量时脾脏重量增加外,未观察到脾脏重量有差异。仅在10和30 mg/kg剂量时观察到脾细胞病毒滴度降低。直至30 mg/kg剂量,未观察到中位生存时间有差异。作者得出结论,氯喹在体内对病毒复制的影响似乎因剂量而异,但对FV诱导的疾病进程没有影响。